Filing search / Context Therapeutics Inc. / "Healthcare"

8-K

EX-10.1

CNTX Context Therapeutics Inc.

23 Sep 24

Context to obtain exclusive development and commercialization rights to BA3362

7:33am

or government, or (z) convicted of a criminal offense related to the provision of healthcare items or services, or is subject to any such pending action (each

424B3

CNTX Context Therapeutics Inc.

31 May 24

Prospectus supplement

4:06pm

of Shares of Common Stock Owned After Offering(2) Percentage of Common Stock Owned After Offering ADAR1 Partners, LP(3) Affinity Healthcare Fund, LP(4 … Private Master Fund I LP(9) Blackwell Partners LLC – Series A(10) Blue Owl Healthcare Opportunities IV Public Investments LP(11) Biomedical Offshore

8-K

EX-99.1

CNTX Context Therapeutics Inc.

2 May 24

Context Therapeutics Announces $100 Million Private Placement

7:37am

Exhibit 99.1 Context Therapeutics Announces $100 Million Private Placement Financing includes new and existing leading healthcare investors … from new and existing investors, including Ally Bridge Group, Avidity Partners, Blackstone Multi-Asset Investing, Blue Owl Healthcare Opportunities, Deep

424B3

wrr7rh rh78fh

9 Nov 22

Prospectus supplement

4:26pm

424B3

231n3xq9ymso6b2s5xd2

12 Apr 22

Prospectus supplement

4:14pm

POS AM

kpc5biis e65

4 Apr 22

Prospectus update (post-effective amendment)

5:08pm

10-K

yl2irjjx jo

23 Mar 22

Annual report

4:17pm

424B4

6gzc iwuzmc8a7ez

17 Dec 21

Prospectus supplement with pricing info

8:00am

424B4

apzfkcm25 z90908

20 Oct 21

Prospectus supplement with pricing info

5:05pm